Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Curcuminoids, the active polyphenolic compounds in turmeric (Curcuma longa), have been studied for their potential cardiovascular benefits. Several preclinical studies and randomized controlled trials have indicated that curcuminoids possess anti-inflammatory, antioxidant, and lipid-lowering properties. These effects are thought to contribute to cardiovascular protection by reducing endothelial dysfunction, lowering LDL cholesterol, and inhibiting atherosclerotic plaque formation. Some human studies have demonstrated improvements in markers of cardiovascular health, such as reductions in C-reactive protein (CRP), total cholesterol, and triglyceride levels, as well as improved endothelial function.

However, while the mechanistic rationale is strong and early clinical trials are promising, the overall quality and quantity of the evidence are moderate. Many clinical studies have small sample sizes, short durations, and varying formulations or dosages of curcuminoids, which limits the strength of the conclusions. Major cardiology guidelines do not currently recommend curcuminoids as a standard treatment for cardiovascular disease, and more large-scale, high-quality clinical trials are needed to definitively establish efficacy and optimal dosing.

In summary, scientific evidence supports a potential adjunctive role for curcuminoids in cardiovascular health, but more robust evidence is required before it can be routinely recommended for the prevention or treatment of cardiovascular disease.

More about Curcuminoids
More about Cardiovascular Disease

Other ingredients used for Cardiovascular Disease

Other health conditions supported by Curcuminoids

Products containing Curcuminoids